|
1
|
Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?
|
Acta Neurochir (Wien)
|
2012
|
1.57
|
|
2
|
Strategy for treating unruptured vertebral artery dissecting aneurysms.
|
Neurosurgery
|
2011
|
1.05
|
|
3
|
Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
|
J Clin Pharmacol
|
2006
|
0.89
|
|
4
|
Cilostazol improves symptomatic intracranial artery stenosis - Evaluation of cerebral blood flow with single photon emission computed tomography.
|
Surg Neurol Int
|
2011
|
0.85
|
|
5
|
Blood-brain permeability of [3H]-(3-methyl-His2)thyrotropin-releasing hormone (MeTRH) in mice: effects of TRH and its analogues.
|
Drug Metab Pharmacokinet
|
2003
|
0.84
|
|
6
|
Coil embolization of an aneurysm located at the trunk of the persistent primitive trigeminal artery.
|
Neurol Med Chir (Tokyo)
|
2011
|
0.84
|
|
7
|
Endoscopic surgical treatment for pituitary apoplexy in three elderly patients over the age of 80.
|
Acta Neurochir Suppl
|
2011
|
0.84
|
|
8
|
Natural vanadium-containing Mt. Fuji ground water improves hypo-activity of liver insulin receptor in Goto-Kakisaki rats.
|
Mol Cell Biochem
|
2004
|
0.83
|
|
9
|
Physicochemical and pharmacological characterization of novel vasoactive intestinal peptide derivatives with improved stability.
|
Eur J Pharm Biopharm
|
2009
|
0.80
|
|
10
|
A 6-Fr guiding catheter (Slim Guide(®)) for use with multiple microdevices.
|
Surg Neurol Int
|
2012
|
0.80
|
|
11
|
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells.
|
Eur J Biochem
|
2004
|
0.80
|
|
12
|
Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
|
Regul Pept
|
2004
|
0.79
|
|
13
|
Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas.
|
Prostate
|
2004
|
0.78
|
|
14
|
Alpha-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequences.
|
Eur J Pharmacol
|
2004
|
0.78
|
|
15
|
Ruptured cerebral aneurysm associated with a persistent primitive trigeminal artery variant.
|
Surg Neurol Int
|
2011
|
0.78
|
|
16
|
Dissecting aneurysms of the vertebral artery--angiographic patterns at the dissecting site on balloon test occlusion.
|
Neuroradiology
|
2011
|
0.78
|
|
17
|
Reversibility of cognitive disorder after treatment of dural arteriovenous fistulae.
|
Neuroradiology
|
2009
|
0.77
|
|
18
|
Prolonged and regionally progressive symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease.
|
Surg Neurol Int
|
2012
|
0.76
|
|
19
|
Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
|
Cerebrovasc Dis
|
2016
|
0.76
|
|
20
|
Development of a kit to treat subarachnoid hemorrhage by intrathecal simple urokinase infusion (ITSUKI) therapy: preliminary results in patients with World Federation of Neurological Surgery (WFNS) grade V subarachnoid hemorrhage.
|
World Neurosurg
|
2011
|
0.75
|
|
21
|
Spinal arachnoid cyst containing nevus cells in a patient with a large congenital melanocytic nevus: case report.
|
Neurosurgery
|
2004
|
0.75
|
|
22
|
Accurate estimation of motor symptoms by diffusion tensor imaging in a patient with advanced Moyamoya disease.
|
Clin Neurol Neurosurg
|
2012
|
0.75
|
|
23
|
Evaluation of Intracranial Arteriovenous Malformations With Four-Dimensional Arterial-Spin Labeling-Based 3-T Magnetic Resonance Angiography.
|
J Comput Assist Tomogr
|
2016
|
0.75
|
|
24
|
Studies on the transport of thyrotropin-releasing hormone (TRH) analogues in Caco-2 cell monolayers.
|
J Pharm Pharmacol
|
2003
|
0.75
|
|
25
|
Structure-activity relationship of synthetic truncated analogues of vasoactive intestinal peptide (VIP): an enhancement in the activity by a substitution with arginine.
|
Life Sci
|
2004
|
0.75
|